FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 151 filers reported holding FATE THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is 1.11 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $1,642 | +87.0% | 345 | +124.0% | 0.00% | – |
| Q1 2023 | $878 | -81.7% | 154 | -67.6% | 0.00% | – |
| Q4 2022 | $4,793 | -4.1% | 475 | +93.9% | 0.00% | – |
| Q3 2022 | $5,000 | 0.0% | 245 | +31.7% | 0.00% | – |
| Q2 2022 | $5,000 | +25.0% | 186 | +91.8% | 0.00% | – |
| Q1 2022 | $4,000 | -42.9% | 97 | -20.5% | 0.00% | – |
| Q4 2021 | $7,000 | +600.0% | 122 | +408.3% | 0.00% | – |
| Q3 2021 | $1,000 | 0.0% | 24 | +50.0% | 0.00% | – |
| Q2 2021 | $1,000 | -66.7% | 16 | -50.0% | 0.00% | – |
| Q1 2021 | $3,000 | +200.0% | 32 | +166.7% | 0.00% | – |
| Q4 2020 | $1,000 | 0.0% | 12 | -84.2% | 0.00% | – |
| Q3 2019 | $1,000 | -50.0% | 76 | 0.0% | 0.00% | – |
| Q2 2019 | $2,000 | -96.8% | 76 | -99.7% | 0.00% | -100.0% |
| Q4 2016 | $63,000 | – | 25,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 3,379,064 | $131,006,000 | 24.77% |
| Redmile Group, LLC | 12,957,222 | $502,351,000 | 15.68% |
| Grosvenor Holdings, L.L.C. | 1,037,256 | $40,214,000 | 7.85% |
| Casdin Capital, LLC | 3,400,000 | $131,818,000 | 5.91% |
| Ally Bridge Group (NY) LLC | 181,500 | $7,037,000 | 5.22% |
| DAFNA Capital Management LLC | 500,930 | $19,421,000 | 5.06% |
| Deep Track Capital, LP | 2,000,000 | $77,540,000 | 4.97% |
| Artal Group S.A. | 2,000,000 | $77,540,000 | 3.25% |
| Tri Locum Partners LP | 190,345 | $7,380,000 | 2.88% |
| ARK Investment Management | 10,988,182 | $426,012,000 | 1.78% |